CLINICAL SCREENING AND PEER INTERVENTIONS TO PREVENT SUBSTANCE USE IN AT-RISK ADOLESCENTS: A Longitudinal Single-Arm Trial Protocol

Mental health conditions and substance use disorders commonly co-occur and adolescence is a period of increased risk for both. Adolescents with mental health conditions often begin using substances earlier than those without. Early initiation increases the risk of later substance use disorder. We propose to measure the impact of a peer-developed, primary care-based intervention to prevent substance use initiation among adolescents with mental health diagnoses and to evaluate responses to the intervention. This is a single-arm 12-month longitudinal unblinded pilot observational study. Adolescents aged 11-14 receiving pediatric primary care for diagnoses of depression, anxiety, or ADHD who have not yet initiated substance use will be eligible. The intervention involves quarterly assessments of substance use in the primary care office followed by viewing one of four 90-second videos targeting prevention topics like peer pressure for those who remain substance-free. The primary outcome is time to substance initiation, measured using the validated CRAFFT 2.1+N screener. Secondary outcomes include participant acceptance of the intervention, assessed by surveys, and tertiary outcomes will describe characteristics of participants who initiate substance use during the study. We will use Kaplan-Meier survival estimates and descriptive statistics. Subgroup analyses will include age, sex, and diagnosis. This trial targets a vulnerable population with increased risk for future substance use disorder. The intervention seeks to harness the protective effects of positive peer influence within the context of ongoing patient-provider relationships to promote delayed onset of substance use and inform feasibility and design of a future multi-site trial. • Local youth will help design brief prevention videos for at-risk adolescents • Videos include 4 brief relevant and engaging animations reviewed at pediatric visits • Positive peer influence + engaged doctor relationship may delay onset of substance use • Validated CRAFFT 2.1+N will evaluate substance use initiation at quarterly visits • Findings will inform feasibility and design of a larger, multisite trial

Authors

Institutions

Publication Details

Journal
Contemporary Clinical Trials Communications
Published
2026-05-01
DOI
https://doi.org/10.1016/j.conctc.2026.101647
Primary Topic
Substance Abuse Treatment and Outcomes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

CLINICAL SCREENING AND PEER INTERVENTIONS TO PREVENT SUBSTANCE USE IN AT-RISK ADOLESCENTS: A Longitudinal Single-Arm Trial Protocol

Constance van Eeghen, Gail L. Rose, Michelle Shepard, Christine Gallese et al.
Contemporary Clinical Trials Communications
Substance Abuse Treatment and Outcomes
article

CLINICAL SCREENING AND PEER INTERVENTIONS TO PREVENT SUBSTANCE USE IN AT-RISK ADOLESCENTS: A Longitudinal Single-Arm Trial Protocol

Constance van Eeghen, Gail L. Rose, Michelle Shepard, Christine Gallese, Derek Devine
article en

Abstract

Mental health conditions and substance use disorders commonly co-occur and adolescence is a period of increased risk for both. Adolescents with mental health conditions often begin using substances earlier than those without. Early initiation increases the risk of later substance use disorder. We propose to measure the impact of a peer-developed, primary care-based intervention to prevent substance use initiation among adolescents with mental health diagnoses and to evaluate responses to the intervention. This is a single-arm 12-month longitudinal unblinded pilot observational study. Adolescents aged 11-14 receiving pediatric primary care for diagnoses of depression, anxiety, or ADHD who have not yet initiated substance use will be eligible. The intervention involves quarterly assessments of substance use in the primary care office followed by viewing one of four 90-second videos targeting prevention topics like peer pressure for those who remain substance-free. The primary outcome is time to substance initiation, measured using the validated CRAFFT 2.1+N screener. Secondary outcomes include participant acceptance of the intervention, assessed by surveys, and tertiary outcomes will describe characteristics of participants who initiate substance use during the study. We will use Kaplan-Meier survival estimates and descriptive statistics. Subgroup analyses will include age, sex, and diagnosis. This trial targets a vulnerable population with increased risk for future substance use disorder. The intervention seeks to harness the protective effects of positive peer influence within the context of ongoing patient-provider relationships to promote delayed onset of substance use and inform feasibility and design of a future multi-site trial. • Local youth will help design brief prevention videos for at-risk adolescents • Videos include 4 brief relevant and engaging animations reviewed at pediatric visits • Positive peer influence + engaged doctor relationship may delay onset of substance use • Validated CRAFFT 2.1+N will evaluate substance use initiation at quarterly visits • Findings will inform feasibility and design of a larger, multisite trial

Contemporary Clinical Trials Communications
University of Vermont (US), University of Vermont Medical Center (US), Vermont Department of Health (US)
Good health and well-being
Openalex Percentile: Top 4%
Substance Abuse Treatment and Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.